120 related articles for article (PubMed ID: 6363677)
1. Effects of vasoactive intestinal polypeptide on renal function in man.
Calam J; Dimaline R; Peart WS; Singh J; Unwin RJ
J Physiol; 1983 Dec; 345():469-75. PubMed ID: 6363677
[TBL] [Abstract][Full Text] [Related]
2. Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit.
Dimaline R; Peart WS; Unwin RJ
J Physiol; 1983 Nov; 344():379-88. PubMed ID: 6361235
[TBL] [Abstract][Full Text] [Related]
3. Renal function during vasoactive intestinal peptide (VIP) infusions in normal man and patients with liver disease.
Calam J; Unwin RJ; Singh J; Dorudi S; Peart WS
Peptides; 1984; 5(2):441-3. PubMed ID: 6382198
[TBL] [Abstract][Full Text] [Related]
4. Effects of vasoactive intestinal polypeptide infusions on renal function in patients with liver disease.
Calam J; Unwin RJ; Dorudi S; Taylor C; Springer CJ; Peart WS
Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):491-5. PubMed ID: 3271622
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide: a direct renal natriuretic substance.
Duggan KA; Macdonald GJ
Clin Sci (Lond); 1987 Feb; 72(2):195-200. PubMed ID: 3816077
[TBL] [Abstract][Full Text] [Related]
6. Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.
Unwin RJ; Reed T; Thom S; Calam J; Peart WS
Br J Clin Pharmacol; 1987 May; 23(5):523-8. PubMed ID: 3297124
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of gastrin C-terminal tetrapeptide (as pentagastrin) and cholecystokinin octapeptide in conscious rabbit and man.
Calam J; Gordon D; Peart WS; Taylor SA; Unwin RJ
Br J Pharmacol; 1987 Jun; 91(2):307-14. PubMed ID: 3607359
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of renin secretion by vasoactive intestinal peptide.
Porter JP; Reid IA; Said SI; Ganong WF
Am J Physiol; 1982 Sep; 243(3):F306-10. PubMed ID: 7051858
[TBL] [Abstract][Full Text] [Related]
9. Renal electrolyte excretion and renin release during calcium and parathormone infusions in conscious rabbits.
Peart WS; Roddis SA; Unwin RJ
J Physiol; 1986 Apr; 373():329-41. PubMed ID: 3528454
[TBL] [Abstract][Full Text] [Related]
10. Renal sodium excretion following systemic infusion of vasoactive intestinal peptide in the rat.
Lonergan MA; Field MJ
Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):819-24. PubMed ID: 1797446
[TBL] [Abstract][Full Text] [Related]
11. Effect of VIP infusion in water and ion transport in the human jejunum.
Krejs GJ; Fordtran JS; Fahrenkrug J; Schaffalitzky de Muckadell OB; Fischer JE; Humphrey CS; O'Dorisio TM; Said SI; Walsh JH; Shulkes AA
Gastroenterology; 1980 Apr; 78(4):722-7. PubMed ID: 7353759
[TBL] [Abstract][Full Text] [Related]
12. The effect of vasoactive intestinal polypeptide on meal-stimulated gastric acid secretion in man.
Holm-Bentzen M; Christiansen J; Kirkegaard P; Olsen PS; Petersen B; Fahrenkrug J
Scand J Gastroenterol; 1983 Jul; 18(5):659-61. PubMed ID: 6675186
[TBL] [Abstract][Full Text] [Related]
13. Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non-pregnant goat.
Carter AM; Einer-Jensen N; Fahrenkrug J; Ottesen B
J Physiol; 1981 Jan; 310():471-80. PubMed ID: 7230045
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
[TBL] [Abstract][Full Text] [Related]
15. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
[TBL] [Abstract][Full Text] [Related]
16. Effect of vasoactive intestinal peptide on isolated perfused rat kidney.
Rosa RM; Silva P; Stoff JS; Epstein FH
Am J Physiol; 1985 Nov; 249(5 Pt 1):E494-7. PubMed ID: 4061639
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the ventilatory, cardiovascular and metabolic effects of salbutamol, aminophylline and vasoactive intestinal peptide in normal subjects.
Morice AH; Schofield P; Keal EE; Sever PS
Br J Clin Pharmacol; 1986 Aug; 22(2):149-53. PubMed ID: 3756064
[TBL] [Abstract][Full Text] [Related]
18. Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide.
Playford RJ; Benito-Orfila MA; Nihoyannopoulos P; Nandha KA; Cockcroft J; Todd S; Ghatei MA; Domin J; Bloom SR; Calam J
Am J Physiol; 1992 Oct; 263(4 Pt 1):E740-7. PubMed ID: 1415694
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinaemia: effects of pretreatment with bromocriptine and dexamethazone.
Lightman SL; Unwin RJ; Graham K; Dimaline R; McGarrick G
Eur J Clin Invest; 1984 Dec; 14(6):444-8. PubMed ID: 6441721
[TBL] [Abstract][Full Text] [Related]
20. Infusion of vasoactive intestinal polypeptide in man: pharmacokinetics and effect on gastric acid secretion.
Holm-Bentzen M; Christiansen J; Petersen B; Fahrenkrug J; Schultz A; Kirkegaard P
Scand J Gastroenterol; 1981 Apr; 16(3):429-32. PubMed ID: 16435487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
